Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study

por Haag, Georg-Martin, Stocker, Gertraud, Quidde, Julia, Jaeger, Dirk, Lordick, Florian
Publicado 2017

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

por Hacker, Ulrich T., Hasenclever, Dirk, Linder, Nicolas, Stocker, Gertraud, Chung, Hyun‐Cheol, Kang, Yoon‐Koo, Moehler, Markus, Busse, Harald, Lordick, Florian
Publicado 2019

Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer

por Krause, Alina, Stocker, Gertraud, Gockel, Ines, Seehofer, Daniel, Hoffmeister, Albrecht, Bläker, Hendrik, Denecke, Timm, Kluge, Regine, Lordick, Florian, Knödler, Maren
Publicado 2022

Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors

por Topf, Vivien, Kheifetz, Yuri, Daum, Severin, Ballhausen, Alexej, Schwarzer, Andreas, Trung, Kien Vu, Stocker, Gertraud, Aigner, Achim, Lordick, Florian, Scholz, Markus, Knödler, Maren
Publicado 2023

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

por Alberti, Andrea, Stocker, Gertraud, Lordick, Florian, Hacker, Ulrich T., Kobitzsch, Benjamin, Haffner, Ivonne, Baiocchi, Gian Luca, Zamparini, Manuel, Tiberio, Guido A. M., Baronchelli, Carla, Caruso, Arnaldo, Bossi, Paolo, Berruti, Alfredo
Publicado 2023

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctio...

por Lorenzen, Sylvie, Schwarz, Alix, Pauligk, Claudia, Goekkurt, Eray, Stocker, Gertraud, Knorrenschild, Jorge Riera, Illerhaus, Gerald, Dechow, Tobias, Moehler, Markus, Moulin, Jean-Charles, Pink, Daniel, Stahl, Michael, Schaaf, Marina, Goetze, Thorsten Oliver, Al-Batran, Salah-Eddin
Publicado 2023

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPA...

por Chekerov, Radoslav, Arndt, Tjadina, Pietzner, Klaus, Canzler, Ulrich, Wimberger, Pauline, Strauß, Hans-Georg, Mahner, Sven, Woelber, Linn, de Gregorio, Nikolaus, Stocker, Gertraud, von Abel, Ekkehard, Neunhoeffer, Tanja, Belau, Antje Kristina, Mustea, Alexander, Yalinkaya, Isil, Braicu, Elena Ioana, Richter, Rolf, Sehouli, Jalid
Publicado 2023